Medtronic (NYSE: MDT) made a significant neurovascular play earlier this month when it agreed to acquire Scientia Vascular.
Medtronic announced today that it has entered into a definitive agreement to acquire Scientia Vascular for $550 million.
GlobalData analyst Dr Andrew S Thompson’s states Medtronic could significantly grow Scientia’s micro guidewire franchise if they can replicate its US success on the international stage.